Life After Liver Transplant: What to Expect in the First Year

Life after liver transplant is, for most people, a return to normal — a supervised normal. In the latest US registry report, 93.5% of adult recipients of a deceased-donor liver were alive one year after surgery. What separates a good first year from a bad one is rarely the operation; it is whether the medicines are taken on time every day, and whether warning signs reach the team early.
— Dr Chetan Kalal, DM Hepatology, Gleneagles Hospital Mumbai

Let me describe a composite patient, drawn from many I have looked after: a 48-year-old schoolteacher from Nashik, transplanted for cirrhosis from undiagnosed hepatitis B, with his wife as the living donor. Three weeks after surgery he is home, eating, walking the corridor of his building, and already asking two questions — when can he go back to the classroom, and does he really need these tablets for the rest of his life?

Both are good questions. The honest answers are “sooner than you fear” and “yes, without exception”. A liver transplant trades a dying organ for a lifelong partnership with a transplant team, and the first year is when that partnership is built. This article walks you through it: hospital, the medicines and why they must never be missed, the foods and remedies that interfere with them, infection, work, and the symptoms that must bring you back to us the same day. It is written for patients and families in India and abroad who have just been through liver transplant surgery, or are about to be.

The first weeks: hospital, home and the first three months

Most recipients in my unit are in hospital for two to three weeks: a few days in the transplant ICU, the rest on the ward learning the medicines. Pain settles quickly; fatigue lingers and improves week by week. Blood tests run daily, and Doppler ultrasound confirms blood is flowing freely through the new liver. Living-donor recipients — the majority in India — go home with a partial liver that regenerates to near full size over the following weeks, one reason the early tests are so frequent. Donors have their own recovery, covered in living liver donor risks and recovery.

Once home, expect to be seen once or twice a week in the first month, then fortnightly, settling to monthly by the third month. Each visit comes with a tacrolimus level and liver and kidney tests, because this is when the dose is being tuned to you. Your team’s schedule overrides anything written here. Keep a diary — weight, temperature, blood pressure — and bring it. By three months most people feel better than they have in years. That is also when they get careless. Do not.

Why is immunosuppression for life, and what does tacrolimus do to the rest of the body?

Your immune system will never accept the new liver as its own. It can be persuaded to tolerate it, and that persuasion is a daily dose of medicine — usually tacrolimus, with one or two others early on, tapered over the first year to the lowest amount that keeps the liver safe. Stopping is not an option. Not after a year, not after ten, not because the blood tests have been normal for ages. They are normal because of the tablets.

Non-adherence is the silent killer of transplanted livers. A review in Liver Transplantation put the rate of not taking immunosuppressants as prescribed at 15% to 40% among adult recipients, and named it a direct cause of rejection and graft loss. Missed doses, random timings, running out over a long weekend, halving the tablet because of tremor — each shows up months later as a rising bilirubin and a biopsy. Tempted to adjust a dose? Call us instead. Rejection itself is covered in my post on liver transplant rejection.

Tacrolimus is guided by a blood level drawn before the morning tablet, not by a fixed dose, because absorption varies from person to person. Its price is paid mainly by the kidneys, the pancreas and the blood vessels. Ojo and colleagues, in the New England Journal of Medicine, followed 69,321 US recipients of non-kidney organs: 16.5% developed chronic renal failure within a median of 36 months, the five-year risk ranged from 7% to 21% by organ, and its arrival more than quadrupled the risk of death. Hence our obsession with blood pressure and kidney function in the first year.

Diabetes is the other big one. A meta-analysis of 28 studies and 71,257 liver recipients found new-onset diabetes in 18.3% at one year and about 25% at ten, with higher rates in predominantly Asian cohorts. Add raised blood pressure, a fine hand tremor, headaches and a greater susceptibility to infection, and you have the usual tacrolimus side effects. Most are manageable. None is a reason to stop the drug; all are reasons to tell us.

Which medicines, herbs and foods interfere with tacrolimus?

Tacrolimus is broken down by a liver enzyme (CYP3A4) that many other substances block or accelerate. Block it and the level climbs, damaging the kidneys; accelerate it and the level falls, inviting rejection. Several antibiotics, antifungals, blood-pressure tablets, epilepsy medicines and anti-TB drugs do one or the other. So the rule has no exceptions: no new medicine from any doctor, chemist or relative without the transplant team knowing first — the dentist and the ayurvedic practitioner your uncle swears by included.

Herbal and “natural” products deserve a special warning in India. A published review of tacrolimus interactions lists grapefruit, pomelo (chakotra), pomegranate, ginger and turmeric among the CYP3A4 inhibitors that can push the level up, and St John’s wort among those that drag it down. Cooking amounts of turmeric and ginger are not the concern; concentrated supplements and tonics are. Herbal preparations can also injure a liver on their own — see my post on drug- and herb-induced liver injury in India. In a transplanted liver that injury is harder to diagnose and harder to afford.

Painkillers are the everyday trap. Avoid ibuprofen, diclofenac and other NSAIDs unless your team has cleared them; they strain the very kidneys tacrolimus is already stressing. Ask which painkiller is safe for you.

How do I avoid infection after a liver transplant?

The drugs that stop rejection lower your defences, most steeply in the first three to six months while doses are highest. Three kinds of infection matter then. Bacterial infections — chest, urine, wound — which respond to prompt treatment. Viral infections, particularly cytomegalovirus (CMV), a common virus that lies dormant in most adults and can reactivate under immunosuppression; your team will either give preventive medicine or monitor your blood for it. And fungal infections, rarer but serious, which is why we ask you to avoid construction dust, gardening without gloves and damp, mouldy rooms early on.

Food is the part you control. For the first six months, eat freshly cooked food, hot. Avoid raw or undercooked meat and eggs, unpasteurised milk, street food, cut fruit from outside, and salads you have not washed yourself in clean water. Drink boiled or sealed bottled water. Wash hands before every meal — basic, and the single most effective measure there is. Masks in crowds early on are sensible, not paranoid.

Vaccines follow one principle: inactivated vaccines (such as influenza, pneumococcal and hepatitis B) are encouraged after transplant; live vaccines are avoided because the weakened organism can cause disease when immunity is suppressed. Which vaccines and when is your team’s decision, ideally settled before transplant. Household members should keep their own vaccinations current.

Diet, weight, exercise and getting back to work

Before transplant, most of my patients were losing muscle and had to be pushed to eat — the struggle I describe in nutrition in cirrhosis. After transplant the problem reverses. Appetite returns, steroids and tacrolimus push sugar upwards, and the restrictions of the cirrhosis years fall away. In a cohort of 252 liver recipients followed for about six years, metabolic syndrome rose from 5.4% before transplant to 51.9% after, and those who developed it had three times the rate of major heart and vascular events. The liver was saved; the heart became the risk.

So eat for the long game: protein at every meal to rebuild muscle; whole grains, dal, vegetables and fruit; limited sugar, refined flour and fried food; modest salt. There is no special “liver diet” after transplant — the diet that protects a transplanted liver is the one that protects a heart. Weigh yourself weekly and tell us if the trend keeps rising after the first three months.

Exercise begins on the ward with walking and continues daily at home; stationary cycling and light resistance work are reasonable in the first three months. Heavy lifting, abdominal crunches and contact sports wait until the surgical team confirms the abdominal wall has healed — months, not weeks.

Return to work depends on the work. In my experience, desk-based and teaching jobs restart part-time at about three months, physically demanding work closer to six; your team sets the date. The international picture is sobering: a review of studies published since 2000 found only 37% of recipients, on average, in paid employment after transplant (22% to 55% by study), with pre-transplant employment, fatigue and depression the strongest predictors. Start that conversation with your employer before surgery, not after. Families worried about money will find practical notes in my article on liver transplant cost and insurance.

Alcohol, pregnancy, mood and the long view

Alcohol: none. Not a toast at a wedding, not a beer on Sundays, not “only on holidays”. This applies whether your liver failed from alcohol, hepatitis B, fatty liver or an autoimmune disease. A transplanted liver handles alcohol badly, it interferes with the medicines, and in alcohol-related disease a return to drinking is the leading way to lose the second liver. If you feel the pull — many do in the low months — say so. We treat it; we do not judge it.

Pregnancy after transplant is possible and usually goes well, but it is planned, never accidental: wait at least a year with stable liver function, have the medicines reviewed beforehand (some must be swapped before conception), and be managed jointly by the transplant team and a high-risk obstetrician. That means reliable contraception from the day you leave hospital.

Mood deserves its own line. Transplant is a near-death experience followed by months of dependency, steroids that disturb sleep and temper, and a body that does not feel like the old one. Low mood, anxiety and poor sleep are common in the first year and respond to treatment; they also worsen adherence, which is why I ask at every visit.

And the long view, because families ask. In the OPTN/SRTR 2024 report from the United States, 93.5% of adult recipients of a deceased-donor liver were alive at one year and 92.0% of grafts were functioning. Across more than 1,000 transplants in programmes I have worked in, around 300 of them complex cases, survival has been 92%. Beyond the first year the threats change: rejection and infection recede; heart disease, kidney disease, cancer and recurrence of the original disease take their place. That is the whole argument for lifelong follow-up with a transplant hepatologist who knows your history — and, if you are still weighing the decision, for a second opinion on transplant eligibility.

References

1. Lucey MR, Terrault N, Ojo L, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):3–26. PMID 23281277. doi:10.1002/lt.23566
2. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349(10):931–940. PMID 12954741. doi:10.1056/NEJMoa021744
3. Chin YH, Tan HQM, Ng CH, et al. A time-based meta-analysis on the incidence of new onset diabetes after liver transplantation. J Clin Med. 2021;10(5):1045. PMID 33802465. doi:10.3390/jcm10051045
4. Burra P, Germani G, Gnoato F, et al. Adherence in liver transplant recipients. Liver Transpl. 2011;17(7):760–770. PMID 21384527. doi:10.1002/lt.22294
5. Miedziaszczyk M, Bajon A, Jakielska E, et al. Controversial interactions of tacrolimus with dietary supplements, herbs and food. Pharmaceutics. 2022;14(10):2154. PMID 36297591. doi:10.3390/pharmaceutics14102154
6. Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 2011;17(1):15–22. PMID 21254340. doi:10.1002/lt.22198
7. Åberg F. From prolonging life to prolonging working life: tackling unemployment among liver-transplant recipients. World J Gastroenterol. 2016;22(14):3701–3711. PMID 27076755. doi:10.3748/wjg.v22.i14.3701
8. Kwong AJ, Lake JR, Schladt DP, et al. OPTN/SRTR 2024 Annual Data Report: Liver. Am J Transplant. 2026;26(8S1):S214–S320. PMID 42276697. doi:10.1016/j.ajt.2026.05.721